Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The double blind randomized controlled trial will assess the efficacy of oral azithromycin
administered to pregnant women and/or infants during routine care in preventing stillbirths
and mortality through 6-12 months of age in Mali, West Africa, where rates of infant and
under five mortality are among the highest in the world.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore